Implementation of Home Monitoring in Patients With Pulmonary Fibrosis
- Sponsor
- Erasmus Medical Center
- Study ID
- NCT06883448
- Status
- Recruiting
Conditions
- Interstitial Lung Disease (ILD)
- Pulmonary Fibrosis
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Home monitoring care — COMBINATION_PRODUCTPatients in the home monitoring group will receive a home spirometer, pulse oximetry meter, and access to a smartphone or tablet app, where they can perform home based measurements weekly and complete PROMs. Furthermore, this app includes disease specific information and allows for direct communication with the hospital via eConsultation. In the home monitoring group, half of the outpatient clinic visits will alternately be replaced by remote visits via video consultation.
Study Details
The objective of this study is to evaluate the impact of structurally replacing half of the outpatient clinic visits for patients with pulmonary fibrosis by home monitoring and video consultations on patient self-management and health(care) outcomes.
Key Dates
- Start date
- Oct 2, 2024
- Status verified
- Dec 2025
- Primary completion
- Sep 1, 2027
- Completion
- Sep 1, 2027
Study Design
- Enrollment
- 220 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- No Intervention: Hospital-based careHospital-based care involves outpatient clinic visits every three months including in-hospital lung function testing.
- Experimental: Home monitoring carePatients in the home monitoring group will receive a home spirometer, pulse oximetry meter, and access to a smartphone or tablet app, where they can perform home based measurements weekly and complete PROMs. Furthermore, this app includes disease specific information and allows for direct communication with the hospital via eConsultation. In the home monitoring group, half of the outpatient clinic visits will alternately be replaced by remote visits via video consultation.
Primary Outcome Measure
Patient self-management [ Time Frame: Baseline to 12 months ]
Central Contacts
- Delian E. Hofman+31650162675
- Catharina C. Moor
Related Studies
- Role of Genetic Factors in the Development of Lung DiseaseRecruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
- Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)Recruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- Explanted Lung Tissues With Pulmonary FibrosisRecruiting · University of Chicago · Chicago, Illinois
- Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis PatientsPHASE1 · Recruiting · Massachusetts General Hospital · Boston, Massachusetts